On May 6, 2026, Penumbra, Inc. held a special stockholder meeting where shareholders approved a merger agreement with Boston Scientific Corporation, with 28,564,786 votes in favor. The merger will make Penumbra a wholly owned subsidiary of Boston Scientific, pending regulatory approvals.